Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT06331845 2024-03-26

Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma

Phase 2 Not yet recruiting

39 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT06174012 2023-12-18

The Effect of Sodium Fluoride Application on the Prevention of Radiation Caries in NPC Patients

Phase 2 Not yet recruiting

135 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT06095167 2023-10-23

Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC

Phase 3 Not yet recruiting

476 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05898256 2023-06-12

Cadonilimab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma

Phase 1/2 Not yet recruiting

20 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05780294 2023-03-22

A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC

Phase 3 Not yet recruiting

132 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05717764 2023-02-08

Clinical Study of Mitoxantrone Hydrochloride Liposome Injection Combined With Capecitabine Versus Capecitabine Monotherapy in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma Who Failed Platinum-containing Treatment

Phase 3 Not yet recruiting

500 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05622474 2022-11-18

A Multicenter Randomized Controlled Clinical Study on the Treatment of T3N1M0 High Risk Nasopharyngeal Carcinoma With or Without Induction Chemotherapy Before Concurrent Radiotherapy and Chemotherapy

Phase NA Not yet recruiting

236 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05484375 2022-08-02

Capecitabine Plus Toripalimab Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma After First-line Treatment

Phase 2 Not yet recruiting

40 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05433597 2022-06-27

A Two-blinded, Multicentre, Phase II/III RCT of Concurrent Chemo-radiotherapy Combined or Not Combined With TNF as the Therapy for LA-NPC

Phase 2/3 Not yet recruiting

172 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04605562 2021-09-05

Umbrella Biomarker-Guided Therapy in NPC

Phase 2 Not yet recruiting

206 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04890522 2021-05-18

An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC

Phase 2/3 Not yet recruiting

622 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Neoplasm Metastasis

NCT04215510 2021-02-23

Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRT

Phase 3 Not yet recruiting

286 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04447326 2020-06-25

Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma

Phase 2 Not yet recruiting

106 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03529279 2018-05-18

CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and Radiotherapy

Phase 3 Not yet recruiting

1,324 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03503136 2018-05-11

NX-NPC

Phase 3 Not yet recruiting

632 enrolled

Head & Neck

Nasopharyngeal Carcinoma